2,4-dinitrobenzene sensitization and to a battery of recall skin test antigens were normal, as was the humoral antibody response to tularaemia antigen. Neither hypogammaglobulinaemia nor specific immunoglobulin deficiencies were found. Thus it appears unlikely that generalized defects in host immune responses can account for the high incidence of persistent hepatitis B virus infection found in Ugandan patients with hepatocellular carcinoma.
extrinsic and intrinsic cases tested with house dust, pollens, and Aspergillus fumigatus antigens (Bencard) showed appreciable sensitization in extrinsic asthma but gave values compatible Ugandan patients with hepatocellular carcinoma but in only 3% ofcontrol subjects (Vogel et al., 1970 Sherlock, et al., 1970; Anand and Malaviya, 1971; Bagshawe et al., 1971; Denison, et al., 1971; Teres et al., 1971; Tong et al., 1971; Simons, 1972, personal communication) , although apparently conflicting reports have also appeared (Smith and Blumberg, 1969; Wright et al., 1969; Alpert and Isselbacher, 1971; Welsh et al., 1972) . While it seems plausible that chronic infection with hepatitis B virus might play a part in the aetiology of this disease, other possible explanations exist. In other diseases, such as some leukaemias and lymphomas, Down's syndrome, lepromatous leprosy, and uraemia, host immunological deficiencies have been invoked to explain the high incidence of persistent hepatitis B virus infection (Miller, 1962; Wilson et al., 1965; Waldorf, et al., 1966; Sutnick et al., 1969 (Vogel and Linsell, 1972) . In addition, immunoglobulin determinations were performed on serum from eight healthy Kampala residents, nine patients with miscellaneous non-malignant conditions but without cirrhosis, 10 patients with biopsy-proved cirrhosis without cancer, 18 patients with cancer of non-hepatic origin, and 10 patients with acute viral hepatitis.
SERUM TESTING
Initial and serial serum specimens from patients with hepatocellular carcinoma were tested for H.A.A. by radioimmunoassay 17 using solid-phase techniques (Peterson et al., in press) and AusRIA (Abbott Laboratories), counterelectrophoresis (Gocke and Howe, 1970) , and complement fixation (Shulman and Barker, 1969) and for anti-H.A.A. by passive hemagglutination (Vyas and Shulman, 1970 (Vogel et al., 1970) Circulating Antibody Reactivity.-A subcutaneous injection of 1 ml of Foshay tularaemia vaccine was given to 14 of these same 16 patients and serum hemagglutinating antibodies were measured weekly for four to six weeks (Wright and Feinberg, 1952 , and all patients tested had positive skin reactions to at least two of the four recall antigens (table IV) . (Agarwaal et al., 1970) , diminished responses to skin test antigens (A. I. Sutnick, unpublished) , and low IgM levels (Sutnick, et al., 1970) . Patients with lepromatous leprosy have also been shown to have impaired cellular immune responses (Sutnick et al., 1969) . Although it was initially thought that the increased incidence of H.A.A. in patients with various types of leukaemia was related to their high transfusion requirement, it has since been shown that H.A.A. is found more frequently in.leukaemia than in non-leukaemic patients requiring multiple transfusions. In addition, patients with malignant diseases known to be associated with immunological defects, such as Hodgkin's disease, are more likely to be persistent H.A.A. carriers than patients with chronic myelogenous leukaemia, a disease in which most indices of immune function are normal (Sutnick et al., 1970) .
The present study was designed to test the hypothesis that host immunological deficiencies might explain the significantly increased incidence of persistent H.A.A. in After intra-amniotic injection of hypertonic saline to induce mid-trimester abortion, changes in coagulation factors have been reported which are consistent with disseminated intravascular coagulation (Stander et al., 1971) . In view of this we investigated the coagulation system during induction of midtrimester abortion with prostaglandin F2a and the termination of pregnancy in the first trimester by vacuum aspiration.
Patients and Methods
Twelve patients were studied aged 18 to 37 years (mean 23 years) and parity one to seven, having termination of pregnancy at 14 to 20 weeks' gestation (mean 17 weeks) by extra-amniotic prostaglandin F2a.. Eleven patients were studied aged 18 to 39 years (mean 24 years) and parity one to four, having termination of their pregnancies by vacuum aspiration at eight to 12 weeks' gestation (mean 10 weeks).
Termination by Extra-amniotic Prostaglandin F2ac.-A Foley catheter was inserted through the cervix into the extra-amniotic space and the bulb was inflated with 40 ml of distilled water.
A test dose of 250 [ig of prostaglandin F.cm was injected into the extra-amniotic space via the Foley catheter. If no side effects occurred 750 jig was instilled at two-hourly intervals until abortion took place. Samples of venous blood (18 ml) were withdrawn into a plastic syringe at the following stages: 1, before administration ofprostaglandin F2,i; 2, when uterine contractions were established two to four hours after the first instillation of prostaglandin, 3; immediately after the expulsion of the products of conception; and 4, twenty-four hours after abortion.
Termination by Vacuum Aspiration.-This operation was carried out under general anaesthesia by using a Karman suction curette. Venous blood samples (18 ml) were withdrawn
